CELU (Celularity) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


CELU Celularity Inc CELU
31 GF Score
Price $0.67
GF Value $2.25
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Celularity Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Celularity's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

CELU vs DYAI, IGC, CRVO: Margin of Safety % (DCF FCF Based) Comparison

For the Biotechnology subindustry, Celularity's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celularity Margin of Safety % (DCF FCF Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celularity's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Celularity's Margin of Safety % (DCF FCF Based) falls into.


CELU
31GF Score
Celularity Inc CELU
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Celularity (CELU) Overvalued in 2026?

Based on GuruFocus' analysis, Celularity stock appears to be undervalued. The current stock price of $0.67 is trading 70.1% below its estimated GF Value™ of $2.25. GuruFocus considers Celularity to be Possible Value Trap.

Key valuation signals for CELU:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $2.25 vs. price of $0.67 (70.1% below fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the CELU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Celularity Business Description

Address 170 Park Avenue, Florham Park, NJ, USA, 07932
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
31GF Score

Get the complete analysis for CELU

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price
$2.25
GF Value